Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - Formulators
  4. /Syncom Healthcare Ltd
MomentumDeep Value

Syncom Healthcare Ltd: Stock Analysis & Fundamentals

Updated this week

Syncom Healthcare Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. ROE: -152.0%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

📊Debt increased 43% YoY — leverage rising
👔Promoter stake down 24.9% this quarter

Key Numbers

Current Price
₹4
Market Cap
17 Cr
Valuation
N/A

Other Top Pharma - Formulators Stocks Beating Nifty 500

Sun Pharmaceutical Industries Ltd
Strong • 4w streak
+15.9%
Torrent Pharmaceuticals Ltd
Average • 12w streak
+23.4%
Dr Reddys Laboratories Ltd
Average • 5w streak
+12.6%
Lupin Ltd
Average • 12w streak
+22.1%
Zydus Lifesciences Ltd
Weak
+10.0%
← Back to Pharma - FormulatorsDashboard

Frequently Asked Questions: Syncom Healthcare Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Syncom Healthcare Ltd's latest quarterly results?

Syncom Healthcare Ltd's latest quarterly results (Jun 2021) show

  • PAT Growth YoY: +26.0%
  • Revenue Growth YoY: +9.4%
  • Operating Margin: -225.7%

What is Syncom Healthcare Ltd's price-to-book ratio?

Syncom Healthcare Ltd's price-to-book ratio is 4.7x.

  • Price-to-Book (P/B): 4.7x
  • Book Value per Share: ₹1
  • Current Price: ₹4

Is Syncom Healthcare Ltd a fundamentally strong company?

Syncom Healthcare Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): -20.3%

Is Syncom Healthcare Ltd debt free?

Syncom Healthcare Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹19 Cr

What is Syncom Healthcare Ltd's return on equity (ROE) and ROCE?

Syncom Healthcare Ltd's return ratios over recent years

  • FY2021: ROCE -54.3%
  • FY2022: ROCE -22.6%
  • FY2023: ROCE -20.3%

Is Syncom Healthcare Ltd's cash flow positive?

Syncom Healthcare Ltd's operating cash flow is negative (FY2023).

  • Cash from Operations (CFO): ₹-2 Cr
  • Free Cash Flow (FCF): ₹-4 Cr

What is Syncom Healthcare Ltd's dividend yield?

Syncom Healthcare Ltd currently does not pay a significant dividend (yield 0.00%).

  • Dividend Yield: 0.00%
  • Current Price: ₹4

Who holds Syncom Healthcare Ltd shares — promoters, FII, DII?

Syncom Healthcare Ltd's shareholding pattern (Jun 2021)

  • Promoters: 0.1%
  • DII (Domestic): 0.0%
  • Public: 99.9%

Is promoter holding increasing or decreasing in Syncom Healthcare Ltd?

Syncom Healthcare Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 0.1% (Jun 2021)
  • Previous Quarter: 0.1% (Mar 2021)
  • Change: 0.00% (stable)

Is Syncom Healthcare Ltd a new momentum entry or an established outperformer?

Syncom Healthcare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Syncom Healthcare Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Syncom Healthcare Ltd may be worth studying

  • Currently showing mixed signals — monitor for clearer trend confirmation

What is the investment thesis for Syncom Healthcare Ltd?

Syncom Healthcare Ltd investment thesis summary:

What is the future outlook for Syncom Healthcare Ltd?

Syncom Healthcare Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.